ArticleFrontiers in pediatrics2025
Impact of neonatal hyperbilirubinemia on peripheral neuromuscular development: evidence from muscle fiber conduction velocity measurements.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Neonatal hyperbilirubinemia is a common condition that may impair neurodevelopment, yet its impact on peripheral neuromuscular function remains underexplored. Objective: This study aimed to assess the effects of hyperbilirubinemia on muscle fiber conduction velocity (MFCV) in neonates using surface electromyography (sEMG). Methods: MFCV was estimated from tibialis anterior sEMG recordings during passive and isometric contractions in neonates with and without hyperbilirubinemia. Global and local time-delay strategies were applied. Z-score analysis and repeated-measures ANOVA were used to compare groups, while regression analysis examined MFCV temporal trends. Results: The hyperbilirubinemia group exhibited significantly lower MFCV and Z-score values than controls ( Conclusions: Neonatal hyperbilirubinemia may alter peripheral neuromuscular maturation. sEMG-based MFCV estimation may serve as a potential sensitive and noninvasive electrophysiological biomarker for detecting bilirubin-related neuromuscular impairment in early infancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.